Xiaorong Yang

1.6k total citations · 1 hit paper
73 papers, 1.0k citations indexed

About

Xiaorong Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaorong Yang has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaorong Yang's work include MicroRNA in disease regulation (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaorong Yang is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaorong Yang collaborates with scholars based in China, Sweden and India. Xiaorong Yang's co-authors include Qing Zhou, Yi‐Long Wu, Dechun Zhang, Jinmei Yang, Shichao Li, Yifeng Zhou, Rongrong Yang, Jiachun Lü, Fuman Qiu and Lei Yang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Xiaorong Yang

62 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma

2022 120 citations Lei Yang, Song Dong et al. Journal for ImmunoTherapy of Cancer profile →

Peers

Countries citing papers authored by Xiaorong Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaorong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Yang more than expected).

Fields of papers citing papers by Xiaorong Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Yang. The network helps show where Xiaorong Yang may publish in the future.

Co-authorship network of co-authors of Xiaorong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Yang. A scholar is included among the top collaborators of Xiaorong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Yang. Xiaorong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Natural products in antiparasitic drug discovery: advances, opportunities and challenges 2025 ·Natural Product Reports ·Xiaofei Shang, Lixia Dai, Xinyuan Cao, (unknown), (unknown), Xiaolou Miao, Xiuhui Li, Xiaorong Yang	3
2	The synthesis of nitric oxide regulated by JNK pathway in the pea aphid to defend against bacterial infection 2025 ·Insect Biochemistry and Molecular Biology ·Li Ma, Yaya Liu, Jing Sun, Xiaorong Yang, (unknown), Tingting Zhang, Jingyu Zhao, Zhiqiang Lu, (unknown), (unknown)	0
3	Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study 2024 ·BMC Cancer ·Jia‐Yi Deng, (unknown), Xiaorong Yang, Zhihong Chen, Chong‐Rui Xu, (unknown)	2
4	Redox ^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma 2024 ·OncoImmunology ·Xue‐Wu Wei, (unknown), (unknown), Xue Fan, Chong‐Rui Xu, Zhihong Chen, Fen Wang, Xiaorong Yang, Jia‐Yi Deng, (unknown), (unknown), (unknown), (unknown), (unknown), Wen‐Zhao Zhong, Jin‐Ji Yang, Xu‐Chao Zhang, (unknown), Yi‐Long Wu, Qing Zhou	11
5	Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Jia‐Yi Deng, (unknown), Lingling Yang, Zhihong Chen, (unknown), Xiaorong Yang, Hong‐Hong Yan, Xue‐Wu Wei, (unknown), Jian Su, Wen‐Zhao Zhong, Chong‐Rui Xu, Yi‐Long Wu, Qing Zhou	23
6	Improving statins production: From non‐genetic strategies to genetic strategies 2023 ·Biotechnology Journal ·(unknown), (unknown), Xiaorong Yang, Fengguang Zhao, Shuangyan Han	2
7	Application of Microteaching Combined with Problem-Based Learning (PBL) Teaching Model in Teaching Clinical Nursing Interns in Otorhinolaryngology Department 2023 ·Journal of Contemporary Educational Research ·Xiaorong Yang, Juan Yao, Tingting Jiang, Ruiqi Li	0
8	Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma breakdown → 2022 ·Journal for ImmunoTherapy of Cancer ·Lei Yang, (unknown), Song Dong, Xue‐Wu Wei, Zhihong Chen, Bo Zhang, Weidong Chen, Xiaorong Yang, Fen Wang, (unknown), Wen‐Zhao Zhong, Yi‐Long Wu, Qing Zhou	120
9	Clinical outcomes of non–small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments 2021 ·European Journal of Cancer ·Mei-Mei Zheng, Hai‐Yan Tu, Jin‐Ji Yang, Xu‐Chao Zhang, Qing Zhou, Chong‐Rui Xu, Ben‐Yuan Jiang, Xue‐Ning Yang, Xiaorong Yang, Jia‐Yi Deng, (unknown), Bing-Fei Xu, Xiu‐Mei Chen, Yang-Si Li, Yi‐Long Wu	19
10	Long transcripts minus touchdown qPCR (LTMT-qPCR): a simplified and convenient method for the screening and quantification of microRNA profile 2021 ·Laboratory Investigation ·Xi Wang, Yixiao Feng, (unknown), Xiaorong Yang, Yan Liu, Peng Qi, Xuehua Kong, Lan Zhou, Zongyue Zeng	3
11	Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC 2020 ·Journal of Thoracic Oncology ·Mei-Mei Zheng, Yang-Si Li, Hai‐Yan Tu, Ben‐Yuan Jiang, Jin‐Ji Yang, Qing Zhou, Chong‐Rui Xu, Xiaorong Yang, Yi‐Long Wu	50
12	Serum MicroRNA Profiling and Bioinformatics of Patients with Spleen‐Deficiency Syndrome 2016 ·Evidence-based Complementary and Alternative Medicine ·Ze‐Min Yang, Long‐Hui Chen, Min Hee Hong, Yingyu Chen, Xiaorong Yang, (unknown), (unknown), Zhenyu He, Weiwen Chen	7
13	Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy 2015 ·Clinical Cancer Research ·Fuman Qiu, Lei Yang, Xiaoxuan Ling, Rongrong Yang, Xiaorong Yang, Lisha Zhang, (unknown), (unknown), Dongsheng Huang, Yifeng Zhou, Jiachun Lü	29
14	Polymorphisms ofNFκB1andIκBαand Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility 2015 ·BioMed Research International ·(unknown), Fuman Qiu, Lei Yang, Rongrong Yang, Xiaorong Yang, Dongsheng Huang, (unknown), Lisha Zhang, Qingping Jiang, Lan Zhang, Yifeng Zhou, Jiachun Lü	9
15	Age Differences of Salivary Alpha-Amylase Levels of Basal and Acute Responses to Citric Acid Stimulation Between Chinese Children and Adults 2015 ·Frontiers in Physiology ·Ze‐Min Yang, Long‐Hui Chen, Min Zhang, (unknown), Jie Zhang, Weiwen Chen, Xiaorong Yang	15
16	Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines 2015 ·Journal of Orthopaedic Surgery and Research ·Xiaorong Yang, Yan Xiong, Hong Duan, (unknown)	20
17	Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysis 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Liuyang Zhao, Na Yu, (unknown), Yixuan Hou, Zongyue Zeng, Xiaorong Yang, Ping Hu, Xi Tang, Jian Wang, Manran Liu	33
18	Effects of a Functional Variant c.353T>C in Snai1 on Risk of Two Contextual Diseases. Chronic Obstructive Pulmonary Disease and Lung Cancer 2014 ·American Journal of Respiratory and Critical Care Medicine ·Lei Yang, Xiaorong Yang, Weidong Ji, Jieqiong Deng, Fuman Qiu, Rongrong Yang, (unknown), Lisha Zhang, Dongsheng Huang, (unknown), Haibo Zhang, Nanshan Zhong, Pixin Ran, Yifeng Zhou, Jiachun Lü	33
19	The roles of AMY1 copies and protein expression in human salivary α-amylase activity 2014 ·Physiology & Behavior ·Ze‐Min Yang, (unknown), Long‐Hui Chen, Min Zhang, Weiwen Chen, Xiaorong Yang	25
20	Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: A systematic review with meta-analysis 2013 ·Clinical Biochemistry ·Xiaorong Yang, (unknown), Zongyue Zeng, Liuyang Zhao, Ping Hu, (unknown), Xi Tang, (unknown), (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact